Raise closed, search for fresh raises on Seedstage

Eugene, CA

Development and market expansion of a sleep therapy device to enhance sleep and cognitive health.

• Mission: Transforming sleep therapy with innovative, non-invasive technology to improve sleep quality and cognitive health.  
• Innovation: Developing the Neurosom Sleep Therapy device, which uses patented electrical stimulation and machine learning to enhance deep sleep.  
• Market Opportunity: Addressing growing demand for effective, at-home sleep solutions for individuals with insomnia and cognitive impairments.  
• Funding Uses: Advancing clinical trials, refining product readiness, and securing regulatory approval for market launch.  
• Leadership: Backed by a team of experts in neuroscience, medical devices, and technology development, driving advancements in sleep therapy.  

Neurosom, Inc. is raising funds to develop and bring to market its non-invasive sleep therapy technology, which aims to improve sleep onset and quality using a wearable device and machine learning to monitor and enhance deep sleep.

The company’s product, Neurosom Sleep Therapy (NST), is designed to assist individuals struggling with insomnia and other cognitive issues by delivering personalized electrical stimulation during sleep.

The funds will primarily be used to advance clinical trials, enhance product readiness, and prepare for regulatory approval, positioning the company to meet growing demands for effective sleep therapy solutions.

Company Info

Neurosom™ develops wearable devices that enhance sleep quality through targeted electrical stimulation and real-time monitoring.

Neurosom™ is a company focused on developing innovative medical devices aimed at enhancing sleep quality through personalized, real-time assessment and therapy. The company has created a wearable device called the Sleep WISP, which utilizes patented technology to deliver targeted electrical stimulation intended to improve deep sleep. The device is designed for home use, allowing individuals to monitor their sleep cycles via EEG and machine learning, facilitating both sleep onset and the extension of deep sleep. Neurosom™ collaborates with research institutions and has received funding for clinical trials to evaluate its effectiveness, particularly in populations with cognitive impairments. The company’s management team consists of experienced professionals with extensive backgrounds in neuroscience, medical devices, and technology development, contributing to its mission of transforming sleep therapy. Neurosom™ has garnered attention in various media outlets.